| 000 | 00974 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516154502.0 | ||
| 264 | 0 | _c20140401 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2013.05.055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInman, Brant A | |
| 245 | 0 | 0 |
_aMaintenance bacillus Calmette-Guérin: why is there continued debate? _h[electronic resource] |
| 260 |
_bEuropean urology _cOct 2013 |
||
| 300 |
_a586-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBCG Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aAbern, Michael R | |
| 773 | 0 |
_tEuropean urology _gvol. 64 _gno. 4 _gp. 586-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2013.05.055 _zAvailable from publisher's website |
| 999 |
_c22842630 _d22842630 |
||